Latest News

4/22/2025

Resolutions at Getinge’s Annual General Meeting April 22, 2025

Getinge AB (publ)’s Annual General Meeting (“AGM”) was held on April 22, 2025 in Kongresshallen, Hotel Tylösand, Halmstad, Sweden. At the AGM, the following was resolved.

Regulatory

4/22/2025
Resolutions at Getinge’s Annual General Meeting April 22, 2025

Getinge AB (publ)’s Annual General Meeting (“AGM”) was held on April 22, 2025 in Kongresshallen, Hotel Tylösand, Halmstad, Sweden. At the AGM, the following was resolved.

4/22/2025

Getinge Interim Report January-March 2025: Strong sales and improved earnings – continued focus on customer value and profitability going forward

“We are entering 2025 with healthy organic sales growth and improved adjusted operating profit despite headwinds from currency effects,” says Mattias Perjos, President & CEO at Getinge. The medtech company’s net sales increased organically by 6.2% while the order intake rose by 2.9% organically.

Regulatory

4/22/2025
Getinge Interim Report January-March 2025: Strong sales and improved earnings – continued focus on customer value and profitability going forward

“We are entering 2025 with healthy organic sales growth and improved adjusted operating profit despite headwinds from currency effects,” says Mattias Perjos, President & CEO at Getinge. The medtech company’s net sales increased organically by 6.2% while the order intake rose by 2.9% organically.

4/8/2025

Getinge invites fund managers, analysts, and media to Q1 Report 2025 conference call

Getinge will issue its Q1 Report 2025 on April 22, 2025, at 12.00 p.m. CEST, followed by a conference call at 13:00 p.m. CEST, hosted by Mattias Perjos, President & CEO, and Agneta Palmér, CFO.

Press release

4/8/2025
Getinge invites fund managers, analysts, and media to Q1 Report 2025 conference call

Getinge will issue its Q1 Report 2025 on April 22, 2025, at 12.00 p.m. CEST, followed by a conference call at 13:00 p.m. CEST, hosted by Mattias Perjos, President & CEO, and Agneta Palmér, CFO.

3/27/2025

Getinge publishes Annual Report for 2024

Today, Getinge publishes its Annual Report, including Sustainability Report, for 2024. The report summarizes a year characterized by strong growth, increased customer satisfaction, and successful product launches. The global medtech company has reached new sales records, strengthened its acquisitions, and continued to develop innovative solutions that improve healthcare – all while maintaining a strong focus on quality improvements and adapting to increasing market demands.

Regulatory

3/27/2025
Getinge publishes Annual Report for 2024

Today, Getinge publishes its Annual Report, including Sustainability Report, for 2024. The report summarizes a year characterized by strong growth, increased customer satisfaction, and successful product launches. The global medtech company has reached new sales records, strengthened its acquisitions, and continued to develop innovative solutions that improve healthcare – all while maintaining a strong focus on quality improvements and adapting to increasing market demands.

3/20/2025

Embracing Getinge’s purpose

Meet Alisa Stafford, an Office Administrator at Getinge who recently took on a new challenge by stepping in front of the camera to represent the company’s purpose to make life-saving technology accessible to more people.

Press release

3/20/2025
Embracing Getinge’s purpose

Meet Alisa Stafford, an Office Administrator at Getinge who recently took on a new challenge by stepping in front of the camera to represent the company’s purpose to make life-saving technology accessible to more people.

2/27/2025

Getinge’s new DPTE®-FLEX Alpha port enables gloveless component transfer, minimizing human intervention and contamination risks in pharmaceutical production

Getinge is introducing its new DPTE®-FLEX, a manual, externally openable port. This new port enhances safety, efficiency, and compliance in pharmaceutical manufacturing by allowing secure, gloveless transfers, which reduces human intervention and contamination risks. This complements their existing products, the DPTE®-XS and DPTE®-EXO Alpha ports.

Press release

2/27/2025
Getinge’s new DPTE®-FLEX Alpha port enables gloveless component transfer, minimizing human intervention and contamination risks in pharmaceutical production

Getinge is introducing its new DPTE®-FLEX, a manual, externally openable port. This new port enhances safety, efficiency, and compliance in pharmaceutical manufacturing by allowing secure, gloveless transfers, which reduces human intervention and contamination risks. This complements their existing products, the DPTE®-XS and DPTE®-EXO Alpha ports.

Company Newsroom

Subscribe to our news feed

A question?

Resolutions at Getinge’s Annual General Meeting April 22, 2025

4/22/2025
Resolutions at Getinge’s Annual General Meeting April 22, 2025

Getinge Interim Report January-March 2025: Strong sales and improved earnings – continued focus on customer value and profitability going forward

4/22/2025
Getinge Interim Report January-March 2025: Strong sales and improved earnings – continued focus on customer value and profitability going forward

Getinge invites fund managers, analysts, and media to Q1 Report 2025 conference call